OZURDEX is a Intravitreal Implant in the Human Prescription Drug category. It is labeled and distributed by Allergan, Inc.. The primary component is Dexamethasone.
Product ID | 0023-3348_04b2b881-a84c-417c-ba09-8a76cf46faea |
NDC | 0023-3348 |
Product Type | Human Prescription Drug |
Proprietary Name | OZURDEX |
Generic Name | Dexamethasone |
Dosage Form | Implant |
Route of Administration | INTRAVITREAL |
Marketing Start Date | 2009-09-01 |
Marketing Category | NDA / NDA |
Application Number | NDA022315 |
Labeler Name | Allergan, Inc. |
Substance Name | DEXAMETHASONE |
Active Ingredient Strength | 1 mg/1 |
Pharm Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2009-09-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA022315 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2009-09-01 |
Marketing Category | NDA |
Application Number | NDA022315 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2009-09-01 |
Ingredient | Strength |
---|---|
DEXAMETHASONE | .7 mg/1 |
SPL SET ID: | 4b204f44-6e8a-4d17-803c-268f0b04679f |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0023-3348 | OZURDEX | dexamethasone |
0054-3177 | Dexamethasone | Dexamethasone |
0054-4179 | Dexamethasone | Dexamethasone |
0054-4180 | Dexamethasone | Dexamethasone |
0054-4181 | Dexamethasone | Dexamethasone |
0054-4182 | Dexamethasone | Dexamethasone |
0054-4183 | Dexamethasone | Dexamethasone |
0054-4184 | Dexamethasone | Dexamethasone |
0054-4186 | Dexamethasone | Dexamethasone |
0054-8174 | Dexamethasone | Dexamethasone |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
OZURDEX 77717722 3773304 Live/Registered |
Allergan, Inc. 2009-04-20 |